SGEM#377: You Don’t Have to “AcT” that Way – TNK for Acute Ischemic Stroke?

Date: September 20th, 2022 Reference: Menon et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. The Lancet 2022 Guest Skeptic: Professor Daniel Fatovich is an emergency physician and clinical researcher based at Royal Perth Hospital, Western Australia. He is Head of the Centre […] The post SGEM#377: You Don’t Have to “AcT” that Way – TNK for Acute Ischemic Stroke? first appeared on The Skeptics Guide to Emergency Medicine.